Physician profile
Heather Dodder West
NPI 1891805040
$527.31
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $212 · 2023: $256 · 2024: $60.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $69.62 | 2023 | Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $53.70 | 2022 | |
| Lilly USA, LLC | $52.38 | 2022-2024 | Mounjaro |
| Merck Sharp & Dohme LLC | $51.82 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.54 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $40.85 | 2022-2023 | Tezspire |
| Hologic Sales and Service, LLC | $40.69 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Edwards Lifesciences Corporation | $27.78 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $23.02 | 2023 | |
| Sumitomo Pharma America, INC. | $21.59 | 2023 | Gemtesa |
| Alkermes, INC. | $20.65 | 2023 | Aristada, Lybalvi |
| Lundbeck LLC | $19.09 | 2023 | Rexulti |
| Glaxosmithkline, LLC. | $18.60 | 2024 | Shingrix |
| Ironshore Pharmaceuticals INC. | $16.29 | 2023 | Jornay Pm |
| Dexcom, INC. | $13.35 | 2023 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.